Navigation Links
CIGNA Group Insurance Celebrates Return to Work Success During National Rehabilitation Awareness Week
Date:9/19/2007

PHILADELPHIA, Sept. 19 /PRNewswire-FirstCall/ -- On a routine stop at the supermarket in November 2006, Leah Freesmeier fell to the ground, hitting the left side of her head on the cement floor and leaving her with a severe injury to her brain. The injury left her with language and hearing impairments, aphasia and right cranial nerve/facial palsy. She doesn't remember falling, or most of the three weeks she was in the hospital, but she does remember the rehabilitation she went through that enabled her to return to her job as a customer support specialist.

"I was lucky to have CIGNA during this ordeal," said Freesmeier. "Not only was the company great at assisting me with the overwhelming process of understanding the various administrative aspects I had to take care of, but my rehabilitation counselor worked very closely with me to ensure I had the best care possible to enable me to get back to work, which was my ultimate goal."

After intense physical and speech therapy, Freesmeier worked with a CIGNA vocational rehabilitation counselor and was ready to return to work six months after her injury. CIGNA's vocational rehabilitation counselors are educated and skilled in helping individuals with disabilities make career plans, learn new skills and face their fears. They understand and anticipate these fears and provide support, education and resources to overcome them.

Freesmeier's CIGNA vocational rehabilitation counselor began the process of helping her plan her return to work. This included assessing factors that could potentially impact the success of her return-to-work plan and determining how some challenges could be reduced or avoided altogether. Additionally, the counselor worked with all of Freesmeier's treating physicians to facilitate easing her back into the workplace. Based on their recommendations, the counselor worked with the local state rehabilitation agency to arrange for Freesmeier to be accompanied by an onsite coach for the
'/>"/>

SOURCE CIGNA
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. CIGNA HealthCare Teams With HopeLab to Help Blast Teen Cancer
2. No link between blood groups and prostate cancer
3. Consumer group seeks Sibutramine ban
4. Suicide risk high in 12-17 Age Group
5. Religious groups overcome objections to cervical cancer vaccines
6. Wockhardt Group Plans Hospital In Delhi By End-2007
7. Group Suicides On The Rise In Japan
8. Yogic Moments: Age Old Yoga, Benefits All Age Groups
9. Group Jogging More Beneficial To Health Than Solo Jogging
10. Plastic Surgery Is Primetime among Ethnic Groups
11. Study Finds Online Support Groups Emotionally Benefit Women Suffering From
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...mmune response after antiretroviral therapy may be... 25 (HealthDay News) -- A new study challenges the... impairs the immune system,s ability to restore it...tive antiretroviral therapy (HAART). , From 50 ...re also infected with HCV. Intravenous drug use is...
(Date:7/25/2008)..., July 25 /PRNewswire/ -- BeaconEquity.com announc...ng news today., Investors can view all of the dai...conEquity.com/m , Today,s Trade Alerts include: D...rook Pharmaceuticals Inc. (Nasdaq: MBRK ), NovaMe... ), Affymetrix Inc. (Nasdaq: AFFX ) and,Abaxis In...
(Date:7/25/2008)...Relationship Based on Significant Improvements in ... MDdatacor, Inc., a leader in health,care quality ...s, today,announced it has entered into a long-term...ort Wellmark,s Collaboration on Quality(SM) Incent...tion between Wellmark and,primary care clinicians ...
(Date:7/25/2008)...AD, Calif., July 25 /PRNewswire/ -- AutoGenomics, ...ion statement on Form S-1 with the,Securities and ...al public,offering of shares of its common stock. ..., all of which are expected to be offered by,AutoG...g, have not yet been,determined., J.P. Morgan Sec...
Breaking Medicine News(10 mins):Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2
...ios Spanos was shocked when his doctor discovered ... his body’s largest blood vessel, the aorta, durin...o symptoms, and was relieved to find out that the ...had been caught while it was still small. For the...
... A brewery in Japan launched production of unusual...farmer who was looking for ways to put his milk su...k will be available in the store shelves Thursday,...akashibetsu, on the country's northernmost island ...
... are planning to whiten your teeth by bleaching th...it done by unqualified people could cause consider...alons are offering teeth whitening by unqualified ...l bleach," said Christopher Orr, president of the ...
...tors and nurses who work in the developing world w...challenges, according to ‘Meeting the Health needs... The BMA’s International Committee surveyed 79 UK...including 67 doctors, who had recently worked in A...
Other Medicine News:Health News:Early Detection of Artery Weakening Can Be a Life-Saver 2Health News:Early Detection of Artery Weakening Can Be a Life-Saver 3Health News:Health Workers Need Better Preparation for Developing World 2
(Date:7/23/2008)...publication in July print edition of Clinical ...IANAPOLIS, July 23 /- A Roche Diagnos...-terminal pro-B-type natriuretic peptide,(NT-proBN...isk,stratification in predicting the risk of cardi...ed with non-steroidal anti-inflammatory drugs of,t...
(Date:7/23/2008)...Areas of the Body Have Greater Concentrations of,S...wswire-USNewswire/ -- Fat removed,from the lower a...nd to be,an excellent source of stem cells, with h... the body, reports a Brazilian-based study in Augu...ficial medical journal of the,American Society of ...
(Date:7/22/2008)...uly 22 /- Following a,thoro...d of Progen,Pharmaceuticals Limited (ASX: PGL; Nas...d the PI-88 phase 3 study in liver cancer. Progen ...xisting portfolio of compounds and,the company wil...d,opportunities through Merger & Acquisition activ...
(Date:7/22/2008)...uss Development Plan Completed Successfully, DUBL...rin Corporation,plc (NASDAQ: AMRN ) today announc... the U.S. Food and Drug Administration (FDA) to di...e treatment of,hypertriglyceridemia. Following the... 3 with AMR101 in hypertriglyceridemia., Dr. Decl...
Breaking Medicine Technology:Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 3Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 4Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Whole Foods Market 28R 29 Announces Eco Conscious Youth Hosts for Whole Earth Generation 28TM 29 Show 15624 1Whole Foods Market 28R 29 Announces Eco Conscious Youth Hosts for Whole Earth Generation 28TM 29 Show 15624 2Whole Foods Market 28R 29 Announces Eco Conscious Youth Hosts for Whole Earth Generation 28TM 29 Show 15624 3Whole Foods Market 28R 29 Announces Eco Conscious Youth Hosts for Whole Earth Generation 28TM 29 Show 15624 4Crannose 28TM 29 Extra Strength Womens Health Formula Targets Urinary Tract Infections 15620 1Crannose 28TM 29 Extra Strength Womens Health Formula Targets Urinary Tract Infections 15620 2Tengion Announces European Orphan Drug Designation for Neo Bladder Augment 4328 1Tengion Announces European Orphan Drug Designation for Neo Bladder Augment 4328 2China Bio Energy Reports Fiscal 2007 Financial Results 4324 1China Bio Energy Reports Fiscal 2007 Financial Results 4324 2China Bio Energy Reports Fiscal 2007 Financial Results 4324 3China Bio Energy Reports Fiscal 2007 Financial Results 4324 4China Bio Energy Reports Fiscal 2007 Financial Results 4324 5China Bio Energy Reports Fiscal 2007 Financial Results 4324 6China Bio Energy Reports Fiscal 2007 Financial Results 4324 7China Bio Energy Reports Fiscal 2007 Financial Results 4324 8China Bio Energy Reports Fiscal 2007 Financial Results 4324 9China Bio Energy Reports Fiscal 2007 Financial Results 4324 10China Bio Energy Reports Fiscal 2007 Financial Results 4324 11
...s Efficacy at Improving Glycemic Control and,Reduc..., Ill., June 23, 2007 /PRNewswire/ -- VeroScience,...rtner S2 Therapeutics,Inc., reported today the re...the overall and cardiovascular safety of Cycloset(...mesylate) in subjects,with type 2 diabetes. The st...
...--Jun 25, 2007 - HepaLife Technologies, Inc.,(OTCB...that new,data presented at an international influe...,s patented PBS-1 cell line outperforms,current ce...us,inside its cells. The most important step towar...against a targeted virus is the,ability to efficie...
Other Medicine Technology:Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 2Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 3Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 4Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 5HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 2HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 3HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 4HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 5HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 6
...y Biotech Captia™ Varicella- Zoster Virus (VZV...s intended for the detection and quantitative dete...dividual serum specimens may be used for the deter...convalescent, may be used to demonstrate seroconve...
The DSL-05-10-VZM Varicella Zoster IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Varicella Zoster Virus in human serum. This as
The Trinity Biotech Mumps IgM Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the qualitative detection of IgM antibody in human serum to Mumps for the determination of immunological experi
The DIAGNOSTIC AUTOMATION, INC. (DAI) Mumps IgG Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the detection and quantitative determination of IgG antibody to Mumps virus in human sera. In
Medicine Products: